PUGLISI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 67
Continente sconosciuto - Info sul continente non disponibili 26
EU - Europa 15
AS - Asia 7
Totale 115
Nazione #
US - Stati Uniti d'America 58
IT - Italia 12
BD - Bangladesh 6
CA - Canada 4
NL - Olanda 2
AG - Antigua e Barbuda 1
CR - Costa Rica 1
GT - Guatemala 1
MY - Malesia 1
PR - Porto Rico 1
SE - Svezia 1
SV - El Salvador 1
Totale 89
Città #
San Jose 19
Council Bluffs 8
Ashburn 7
Milan 7
Santa Clara 6
Boston 2
Indpls 2
Montreal 2
Caguas 1
Cleveland 1
Guatemala City 1
Immokalee 1
Ironton 1
Irvine 1
Kuala Lumpur 1
Lake Country 1
Linden 1
Memphis 1
Miano 1
Montesilvano 1
New Bedford 1
New York 1
Parma 1
Phoenix 1
Plano 1
San José 1
San Salvador 1
Seattle 1
St John's 1
Willmar 1
Windsor 1
Yorktown Heights 1
Totale 77
Nome #
News from the San Antonio Breast Cancer Symposium 2022 20
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease 19
The role of the molecular tumor board: learnings from the ROME trial 15
Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance 13
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 12
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review 12
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach 12
Positioning of Tucatinib in the New Clinical Scenario of HER2-Positive Metastatic Breast Cancer: An Italian and Spanish Consensus Paper 10
Corrigendum to “Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review” [Cancer Treatm. Rev. 114 (2023) 102511] (Cancer Treatment Reviews (2023) 114, (S0305737223000026), (10.1016/j.ctrv.2023.102511)) 2
Totale 115
Categoria #
all - tutte 418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/202635 0 0 0 0 0 0 0 0 0 0 2 33
2026/202780 23 57 0 0 0 0 0 0 0 0 0 0
Totale 115